Drug Trial Radar · NCT06660563
A Study of JNJ-80948543 in Combination With Other CD3 T-Cell Engagers in Participants With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (R/R B-Cell NHL)
Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
19
Actual
Start
Oct 22, 2024
Primary completion
Jan 19, 2026
Study completion Mar 31, 2027
Sponsor
- Lead sponsor
- Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
- Sponsor type
- Industry
- First posted
- Oct 28, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine the recommended phase 2 regimen (RP2R) for JNJ-80948543 in combination with JNJ-75348780 (Part 1: Dose Escalation) and to further assess the safety of JNJ-80948543 at the RP2R in combination with JNJ-75348780 (Part 2: Dose Expansion).
Conditions
- Lymphoma, Non-Hodgkin
Interventions
JNJ-80948543Drug
JNJ-80948543 will be administered as subcutaneous (SC) or intravenous (IV) injection.
JNJ-75348780Drug
JNJ-75348780 will be administered as SC injection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants with Dose-limiting Toxicity (DLT)Time frame: Up to 1 year and 10 months
- Number of Participants with Adverse Events (AEs)Time frame: Up to 1 year and 10 months
Locations
11 sites in 4 countries. Site status is shown where the registry gives one.
Concord Hospital
Concord, Australia
St Vincents Hospital Melbourne
Fitzroy, Australia
Macquarie University Hospital
North Ryde, Australia
Hosp Univ Vall D Hebron
Barcelona, Spain
Hosp. Clinic de Barcelona
Barcelona, Spain
Inst. Cat. Doncologia-H Duran I Reynals
L'Hospitalet de Llobregat, Spain
Hosp. Gral. Univ. Gregorio Maranon
Madrid, Spain
Hosp. Univ. 12 de Octubre
Madrid, Spain
China Medical University Hospital
Taichung, Taiwan
National Taiwan University Hospital
Taipei, Taiwan
University Hospitals Of Leicester Nhs Trust
Leicester, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.